Skip to main content
Top
Published in: International Urology and Nephrology 1/2015

01-01-2015 | Urology - Original Paper

Effectiveness of partial adrenalectomy for concomitant hypertension in patients with nonfunctional adrenal adenoma

Authors: Tianyuan Xu, Leilei Xia, Xianjin Wang, Xiaohua Zhang, Shan Zhong, Liang Qin, Xiang Zhang, Yu Zhu, Zhoujun Shen

Published in: International Urology and Nephrology | Issue 1/2015

Login to get access

Abstract

Objective

To evaluate the effect of adrenal surgery on blood pressure (BP) in patients with both nonfunctional adrenal adenoma (NFA) and hypertension and to assess factors affecting hypertension outcomes after surgery.

Methods

Nonfunctional adrenal adenoma patients with hypertension who were treated with or without adrenal surgery at our center during 2005–2011 were retrospectively studied. Clinical characteristics were collected, and changes in BP were evaluated and compared at 2 year after discharge. Factors predicting favorable hypertension outcomes after surgery were determined using logistic regression.

Results

A total of 186 patients, including 77 surgically treated cases, were eligible for this study. Retroperitoneoscopic procedure was mostly adopted, and partial adrenalectomy was performed in 69 patients. At 2 year postoperatively, both systolic and diastolic pressure levels of the surgery group decreased significantly (162.9/97.6 vs. 146.9/88.2 mmHg), with 27 (35 %) patients cured and 26 (31 %) improved. In contrast, BP levels of conservatively treated patients remained relatively stable (159.9/96.8 vs. 161.9/97.4 mmHg) after 2 years. Multivariate logistic regression analyses showed hypertension duration <6 years was the only independent factor associated with favorable hypertension outcomes after surgery, which predicted complete cure as well as response to surgical intervention.

Conclusion

Early partial adrenalectomy substantially cures or improves concomitant hypertension in most patients with NFA. Prospective studies should be performed of large cohorts to construct ideal clinical guidelines for NFA patients at cardiometabolic risk.
Literature
1.
go back to reference Androulakis II, Kaltsas G, Piaditis G, Grossman AB (2011) The clinical significance of adrenal incidentalomas. Eur J Clin Invest 41:552–560PubMedCrossRef Androulakis II, Kaltsas G, Piaditis G, Grossman AB (2011) The clinical significance of adrenal incidentalomas. Eur J Clin Invest 41:552–560PubMedCrossRef
2.
go back to reference Zeiger MA, Thompson GB, Duh QY, Hamrahian AH, Angelos P, Elaraj D, Fishman E, Kharlip J, American Association of Clinical Endocrinologists, American Association of Endocrine Surgeons (2009) American Association of Clinical Endocrinologists and American Association of Endocrine Surgeons medical guidelines for the management of adrenal incidentalomas: executive summary of recommendations. Endocr Pract 15:450–453PubMedCrossRef Zeiger MA, Thompson GB, Duh QY, Hamrahian AH, Angelos P, Elaraj D, Fishman E, Kharlip J, American Association of Clinical Endocrinologists, American Association of Endocrine Surgeons (2009) American Association of Clinical Endocrinologists and American Association of Endocrine Surgeons medical guidelines for the management of adrenal incidentalomas: executive summary of recommendations. Endocr Pract 15:450–453PubMedCrossRef
3.
go back to reference Erbil Y, Ozbey N, Barbaros U, Unalp HR, Salmaslioglu A, Ozarmagan S (2009) Cardiovascular risk in patients with nonfunctional adrenal incidentaloma: myth or reality? World J Surg 33:2099–2105PubMedCrossRef Erbil Y, Ozbey N, Barbaros U, Unalp HR, Salmaslioglu A, Ozarmagan S (2009) Cardiovascular risk in patients with nonfunctional adrenal incidentaloma: myth or reality? World J Surg 33:2099–2105PubMedCrossRef
4.
go back to reference Comlekci A, Yener S, Ertilav S, Secil M, Akinci B, Demir T, Kebapcilar L, Bayraktar F, Yesil S, Eraslan S (2010) Adrenal incidentaloma, clinical, metabolic, follow-up aspects: single centre experience. Endocrine 37:40–46PubMedCrossRef Comlekci A, Yener S, Ertilav S, Secil M, Akinci B, Demir T, Kebapcilar L, Bayraktar F, Yesil S, Eraslan S (2010) Adrenal incidentaloma, clinical, metabolic, follow-up aspects: single centre experience. Endocrine 37:40–46PubMedCrossRef
5.
go back to reference Peppa M, Boutati E, Koliaki C, Papaefstathiou N, Garoflos E, Economopoulos T, Hadjidakis D, Raptis SA (2010) Insulin resistance and metabolic syndrome in patients with nonfunctioning adrenal incidentalomas: a cause-effect relationship? Metabolism 59:1435–1441PubMedCrossRef Peppa M, Boutati E, Koliaki C, Papaefstathiou N, Garoflos E, Economopoulos T, Hadjidakis D, Raptis SA (2010) Insulin resistance and metabolic syndrome in patients with nonfunctioning adrenal incidentalomas: a cause-effect relationship? Metabolism 59:1435–1441PubMedCrossRef
6.
go back to reference Yener S, Ertilav S, Secil M, Akinci B, Demir T, Kebapcilar L, Yesil S (2012) Increased risk of unfavorable metabolic outcome during short-term follow-up in subjects with nonfunctioning adrenal adenomas. Med Princ Pract 21:429–434PubMedCrossRef Yener S, Ertilav S, Secil M, Akinci B, Demir T, Kebapcilar L, Yesil S (2012) Increased risk of unfavorable metabolic outcome during short-term follow-up in subjects with nonfunctioning adrenal adenomas. Med Princ Pract 21:429–434PubMedCrossRef
7.
go back to reference Barry MK, van Heerden JA, Farley DR, Grant CS, Thompson GB, Ilstrup DM (1998) Can adrenal incidentalomas be safely observed? World J Surg 22:599–603PubMedCrossRef Barry MK, van Heerden JA, Farley DR, Grant CS, Thompson GB, Ilstrup DM (1998) Can adrenal incidentalomas be safely observed? World J Surg 22:599–603PubMedCrossRef
8.
go back to reference Siren J, Tervahartiala P, Sivula A, Haapiainen R (2000) Natural course of adrenal incidentalomas: seven-year follow-up study. World J Surg 24:579–582PubMedCrossRef Siren J, Tervahartiala P, Sivula A, Haapiainen R (2000) Natural course of adrenal incidentalomas: seven-year follow-up study. World J Surg 24:579–582PubMedCrossRef
9.
go back to reference Yener S, Genc S, Akinci B, Secil M, Demir T, Comlekci A, Ertilav S, Yesil S (2009) Carotid intima media thickness is increased and associated with morning cortisol in subjects with non-functioning adrenal incidentaloma. Endocrine 35:365–370PubMedCrossRef Yener S, Genc S, Akinci B, Secil M, Demir T, Comlekci A, Ertilav S, Yesil S (2009) Carotid intima media thickness is increased and associated with morning cortisol in subjects with non-functioning adrenal incidentaloma. Endocrine 35:365–370PubMedCrossRef
10.
go back to reference Izaki H, Fukumori T, Takahashi M, Taue R, Kishimoto T, Tanimoto S, Nishitani MA, Kanayama HO (2006) Indications for laparoscopic adrenalectomy for non-functional adrenal tumor with hypertension: usefulness of adrenocortical scintigraphy. Int J Urol 13:677–681PubMedCrossRef Izaki H, Fukumori T, Takahashi M, Taue R, Kishimoto T, Tanimoto S, Nishitani MA, Kanayama HO (2006) Indications for laparoscopic adrenalectomy for non-functional adrenal tumor with hypertension: usefulness of adrenocortical scintigraphy. Int J Urol 13:677–681PubMedCrossRef
11.
go back to reference Expert Panel on Metabolic Syndrome of Chinese Diabetes Society (2004) Recommendations on metabolic syndrome of Chinese diabetes society (Chinese). Chin J Diabet 12:156–161 Expert Panel on Metabolic Syndrome of Chinese Diabetes Society (2004) Recommendations on metabolic syndrome of Chinese diabetes society (Chinese). Chin J Diabet 12:156–161
12.
go back to reference Wang XJ, Shen ZJ, Zhu Y, Zhang RM, Shun FK, Shao Y, Rui WB, He W (2010) Retroperitoneoscopic partial adrenalectomy for small adrenal tumours (< or = 1 cm): the Ruijin clinical experience in 88 patients. BJU Int 105:849–853PubMedCrossRef Wang XJ, Shen ZJ, Zhu Y, Zhang RM, Shun FK, Shao Y, Rui WB, He W (2010) Retroperitoneoscopic partial adrenalectomy for small adrenal tumours (< or = 1 cm): the Ruijin clinical experience in 88 patients. BJU Int 105:849–853PubMedCrossRef
13.
go back to reference He HC, Dai J, Shen ZJ, Zhu Y, Sun FK, Shao Y, Zhang RM, Wang HF, Rui WB, Zhong S (2012) Retroperitoneal adrenal-sparing surgery for the treatment of Cushing’s syndrome caused by adrenocortical adenoma: 8-year experience with 87 patients. World J Surg 36:1182–1188PubMedCrossRef He HC, Dai J, Shen ZJ, Zhu Y, Sun FK, Shao Y, Zhang RM, Wang HF, Rui WB, Zhong S (2012) Retroperitoneal adrenal-sparing surgery for the treatment of Cushing’s syndrome caused by adrenocortical adenoma: 8-year experience with 87 patients. World J Surg 36:1182–1188PubMedCrossRef
14.
go back to reference Young WF Jr (2000) Management approaches to adrenal incidentalomas. A view from Rochester, Minnesota. Endocrinol Metab Clin North Am 29:159–185PubMedCrossRef Young WF Jr (2000) Management approaches to adrenal incidentalomas. A view from Rochester, Minnesota. Endocrinol Metab Clin North Am 29:159–185PubMedCrossRef
15.
go back to reference Ivović M, Marina LV, Tančić-Gajić M, Stojanović M, Radonjić NV, Gajić M, Soldatović I, Micić D (2013) Nondiabetic patients with either subclinical Cushing’s or nonfunctional adrenal incidentalomas have lower insulin sensitivity than healthy controls: clinical implications. Metabolism 62:786–792PubMedCrossRef Ivović M, Marina LV, Tančić-Gajić M, Stojanović M, Radonjić NV, Gajić M, Soldatović I, Micić D (2013) Nondiabetic patients with either subclinical Cushing’s or nonfunctional adrenal incidentalomas have lower insulin sensitivity than healthy controls: clinical implications. Metabolism 62:786–792PubMedCrossRef
16.
go back to reference Sereg M, Szappanos A, Toke J, Karlinger K, Feldman K, Kaszper E, Varga I, Gláz E, Rácz K, Tóth M (2009) Atherosclerotic risk factors and complications in patients with non-functioning adrenal adenomas treated with or without adrenalectomy: a long-term follow-up study. Eur J Endocrinol 160:647–655PubMedCrossRef Sereg M, Szappanos A, Toke J, Karlinger K, Feldman K, Kaszper E, Varga I, Gláz E, Rácz K, Tóth M (2009) Atherosclerotic risk factors and complications in patients with non-functioning adrenal adenomas treated with or without adrenalectomy: a long-term follow-up study. Eur J Endocrinol 160:647–655PubMedCrossRef
17.
go back to reference Ermetici F, Dall’Asta C, Malavazos AE, Coman C, Morricone L, Montericcio V, Ambrosi B (2008) Echocardiographic alterations in patients with non-functioning adrenal incidentaloma. J Endocrinol Invest 31:573–577PubMedCrossRef Ermetici F, Dall’Asta C, Malavazos AE, Coman C, Morricone L, Montericcio V, Ambrosi B (2008) Echocardiographic alterations in patients with non-functioning adrenal incidentaloma. J Endocrinol Invest 31:573–577PubMedCrossRef
18.
go back to reference Yener S, Comlekci A, Akinci B, Secil M, Demir T, Ertilav S, Yesil S (2009) Non-functioning adrenal incidentalomas are associated with elevated D-dimer levels. J Endocrinol Invest 32:338–343PubMedCrossRef Yener S, Comlekci A, Akinci B, Secil M, Demir T, Ertilav S, Yesil S (2009) Non-functioning adrenal incidentalomas are associated with elevated D-dimer levels. J Endocrinol Invest 32:338–343PubMedCrossRef
19.
go back to reference Ermetici F, Malavazos AE, Corbetta S, Morricone L, Dall’Asta C, Corsi MM, Ambrosi B (2007) Adipokine levels and cardiovascular risk in patients with adrenal incidentaloma. Metabolism 56:686–692PubMedCrossRef Ermetici F, Malavazos AE, Corbetta S, Morricone L, Dall’Asta C, Corsi MM, Ambrosi B (2007) Adipokine levels and cardiovascular risk in patients with adrenal incidentaloma. Metabolism 56:686–692PubMedCrossRef
20.
go back to reference Muscogiuri G, Sorice GP, Prioletta A, Mezza T, Cipolla C, Salomone E, Giaccari A, Pontecorvi A, Della Casa S (2011) The size of adrenal incidentalomas correlates with insulin resistance. Is there a cause-effect relationship? Clin Endocrinol (Oxf) 74:300–305CrossRef Muscogiuri G, Sorice GP, Prioletta A, Mezza T, Cipolla C, Salomone E, Giaccari A, Pontecorvi A, Della Casa S (2011) The size of adrenal incidentalomas correlates with insulin resistance. Is there a cause-effect relationship? Clin Endocrinol (Oxf) 74:300–305CrossRef
21.
go back to reference Midorikawa S, Sanada H, Hashimoto S, Suzuki T, Watanabe T (2001) The improvement of insulin resistance in patients with adrenal incidentaloma by surgical resection. Clin Endocrinol (Oxf) 54:797–804CrossRef Midorikawa S, Sanada H, Hashimoto S, Suzuki T, Watanabe T (2001) The improvement of insulin resistance in patients with adrenal incidentaloma by surgical resection. Clin Endocrinol (Oxf) 54:797–804CrossRef
22.
go back to reference Bernini G, Moretti A, Iacconi P, Miccoli P, Nami R, Lucani B, Salvetti A (2003) Anthropometric, haemodynamic, humoral and hormonal evaluation in patients with incidental adrenocortical adenomas before and after surgery. Eur J Endocrinol 148:213–219PubMedCrossRef Bernini G, Moretti A, Iacconi P, Miccoli P, Nami R, Lucani B, Salvetti A (2003) Anthropometric, haemodynamic, humoral and hormonal evaluation in patients with incidental adrenocortical adenomas before and after surgery. Eur J Endocrinol 148:213–219PubMedCrossRef
23.
go back to reference Khorram-Manesh A, Ahlman H, Nilsson O, Friberg P, Odén A, Stenström G, Hansson G, Stenquist O, Wängberg B, Tisell LE, Jansson S (2005) Long-term outcome of a large series of patients surgically treated for pheochromocytoma. J Intern Med 258:55–66PubMedCrossRef Khorram-Manesh A, Ahlman H, Nilsson O, Friberg P, Odén A, Stenström G, Hansson G, Stenquist O, Wängberg B, Tisell LE, Jansson S (2005) Long-term outcome of a large series of patients surgically treated for pheochromocytoma. J Intern Med 258:55–66PubMedCrossRef
24.
go back to reference Pivonello R, Faggiano A, Lombardi G, Colao A (2005) The metabolic syndrome and cardiovascular risk in Cushing’s syndrome. Endocrinol Metab Clin North Am 34:327–339PubMedCrossRef Pivonello R, Faggiano A, Lombardi G, Colao A (2005) The metabolic syndrome and cardiovascular risk in Cushing’s syndrome. Endocrinol Metab Clin North Am 34:327–339PubMedCrossRef
25.
go back to reference Zarnegar R, Young WF Jr, Lee J, Sweet MP, Kebebew E, Farley DR, Thompson GB, Grant CS, Clark OH, Duh QY (2008) The aldosteronoma resolution score: predicting complete resolution of hypertension after adrenalectomy for aldosteronoma. Ann Surg 247:511–518PubMedCrossRef Zarnegar R, Young WF Jr, Lee J, Sweet MP, Kebebew E, Farley DR, Thompson GB, Grant CS, Clark OH, Duh QY (2008) The aldosteronoma resolution score: predicting complete resolution of hypertension after adrenalectomy for aldosteronoma. Ann Surg 247:511–518PubMedCrossRef
26.
go back to reference Kaye DR, Storey BB, Pacak K, Pinto PA, Linehan WM, Bratslavsky G (2010) Partial adrenalectomy: underused first line therapy for small adrenal tumors. J Urol 184:18–25PubMedCentralPubMedCrossRef Kaye DR, Storey BB, Pacak K, Pinto PA, Linehan WM, Bratslavsky G (2010) Partial adrenalectomy: underused first line therapy for small adrenal tumors. J Urol 184:18–25PubMedCentralPubMedCrossRef
27.
go back to reference Fu B, Zhang X, Wang GX, Lang B, Ma X, Li HZ, Wang BJ, Shi TP, Ai X, Zhou HX, Zheng T (2011) Long-term results of a prospective, randomized trial comparing retroperitoneoscopic partial versus total adrenalectomy for aldosterone producing adenoma. J Urol 185:1578–1582PubMedCrossRef Fu B, Zhang X, Wang GX, Lang B, Ma X, Li HZ, Wang BJ, Shi TP, Ai X, Zhou HX, Zheng T (2011) Long-term results of a prospective, randomized trial comparing retroperitoneoscopic partial versus total adrenalectomy for aldosterone producing adenoma. J Urol 185:1578–1582PubMedCrossRef
28.
go back to reference Nakada T, Kubota Y, Sasagawa I, Yagisawa T, Watanabe M, Ishigooka M (1995) Therapeutic outcome of primary aldosteronism: adrenalectomy versus enucleation of aldosterone-producing adenoma. J Urol 153:1775–1780PubMedCrossRef Nakada T, Kubota Y, Sasagawa I, Yagisawa T, Watanabe M, Ishigooka M (1995) Therapeutic outcome of primary aldosteronism: adrenalectomy versus enucleation of aldosterone-producing adenoma. J Urol 153:1775–1780PubMedCrossRef
Metadata
Title
Effectiveness of partial adrenalectomy for concomitant hypertension in patients with nonfunctional adrenal adenoma
Authors
Tianyuan Xu
Leilei Xia
Xianjin Wang
Xiaohua Zhang
Shan Zhong
Liang Qin
Xiang Zhang
Yu Zhu
Zhoujun Shen
Publication date
01-01-2015
Publisher
Springer Netherlands
Published in
International Urology and Nephrology / Issue 1/2015
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-014-0841-8

Other articles of this Issue 1/2015

International Urology and Nephrology 1/2015 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.